These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 8688395)
1. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders. Williamson P; Harris R; Church S; Fiddler M; Rhind J Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395 [TBL] [Abstract][Full Text] [Related]
2. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register. Morris JK; Alberman E BMJ; 2009 Oct; 339():b3794. PubMed ID: 19858532 [TBL] [Abstract][Full Text] [Related]
3. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing. Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939 [TBL] [Abstract][Full Text] [Related]
4. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786 [TBL] [Abstract][Full Text] [Related]
5. Screening for Down's syndrome: experience in an inner city health district. Saridogan E; Djahanbakhch O; Naftalin AA Br J Obstet Gynaecol; 1996 Dec; 103(12):1205-11. PubMed ID: 8968237 [TBL] [Abstract][Full Text] [Related]
6. The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome. Huang T; Watt HC; Wald NJ Prenat Diagn; 1997 Jul; 17(7):615-21. PubMed ID: 9249861 [TBL] [Abstract][Full Text] [Related]
7. Using decision analysis to compare policies for antenatal screening for Down's syndrome. Fletcher J; Hicks NR; Kay JD; Boyd PA BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539 [TBL] [Abstract][Full Text] [Related]
8. Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region. Wellesley D; Boyle T; Barber J; Howe DT BMJ; 2002 Jul; 325(7354):15. PubMed ID: 12098722 [TBL] [Abstract][Full Text] [Related]
9. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening. Leporrier N; Herrou M; Morello R; Leymarie P BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930 [TBL] [Abstract][Full Text] [Related]
10. Results of first year (1989) of a national register of Down's syndrome in England and Wales. Mutton DE; Alberman E; Ide R; Bobrow M BMJ; 1991 Nov; 303(6813):1295-7. PubMed ID: 1836152 [TBL] [Abstract][Full Text] [Related]
11. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277 [TBL] [Abstract][Full Text] [Related]
12. Down's syndrome births and pregnancy terminations in 1989 to 1993: preliminary findings. Alberman E; Mutton D; Ide R; Nicholson A; Bobrow M Br J Obstet Gynaecol; 1995 Jun; 102(6):445-7. PubMed ID: 7632634 [TBL] [Abstract][Full Text] [Related]
13. Prenatal screening for Down's syndrome with use of maternal serum markers. Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344 [TBL] [Abstract][Full Text] [Related]
14. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. Green JM BMJ; 1994 Sep; 309(6957):769-72. PubMed ID: 7950560 [TBL] [Abstract][Full Text] [Related]
15. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909 [TBL] [Abstract][Full Text] [Related]
16. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
17. Use of the disutility ratio in prenatal screening for Down's syndrome. van der Meulen JH; Mol BW; Pajkrt E; van Lith JM; Voorn W Br J Obstet Gynaecol; 1999 Feb; 106(2):108-15. PubMed ID: 10426675 [TBL] [Abstract][Full Text] [Related]
18. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. Boyd PA; Devigan C; Khoshnood B; Loane M; Garne E; Dolk H; BJOG; 2008 May; 115(6):689-96. PubMed ID: 18410651 [TBL] [Abstract][Full Text] [Related]
19. The proportions of Down's syndrome pregnancies detected prenatally in England and Wales from 1989 to 2004. Morris JK; Alberman E; Mutton D J Med Screen; 2006; 13(4):163-5. PubMed ID: 17217603 [TBL] [Abstract][Full Text] [Related]
20. Strategies for antenatal detection of Down's syndrome. Wyllie JP; Madar RJ; Wright M; Burn J; Wren C Arch Dis Child Fetal Neonatal Ed; 1997 Jan; 76(1):F26-30. PubMed ID: 9059182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]